New drug gives hope to heart failure sufferers

By Rory Callinan
Updated September 30 2014 - 10:08am, first published September 1 2014 - 1:25am
Novartis executives say the company will file for approval of the drug, known by the code name LCZ696, in the US by the end of the year. Photo: Peter Rae
Novartis executives say the company will file for approval of the drug, known by the code name LCZ696, in the US by the end of the year. Photo: Peter Rae

A newly developed drug could significantly improve the treatment of heart failure – a condition that is diagnosed in an estimated 30,000 Australians every year.